Click here to get in touch with the Profounda Team.
Toll Free: (800) 407-6810
October 2, 2018
October 22, 2017
December 31, 2016
Sales of Impavido, Rhinase Soothing Nasal Gel and Rhinase Lubricating Mist exceeded $2.5 M for 2016 making it a great start for Profounda as it looks to introduce new products to the market in 2017.
Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.
December 16, 2016
Orphan indication received by Profounda is for the treatment of PAM, also commonly known as the Brain Eating Amoeba
Dec 15, 2016 Profounda, Inc. ("Profounda") announced today that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug...
September 12, 2016
Orlando Channel 6 News
August 12, 2016
April 20, 2016
Profounda has received the necessary licensure from the State of Florida as a Drug Manufacturer which allows it to supply drug directly to those in need.
Impavido (miltefosine) is now available in the USA directly from Profounda for the treatment of leishmania.
Older Posts >
Profounda OutLicenses right to development product
December 6, 2013
Company formation complete
June 1, 2013
Patient survives Brain Eating Amoeba
Generic to Arestin Microspheres by Bausch Health (Orapharma) receives Competitive Generic Therapy Designation
DOG AND HUMANS GET GREAT RESULTS
Sales exceed $2 Million for first year of Profounda's Commercial Presence in the USA
Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine
Profounda Inc. receives FDA orphan-drug designation for the Treatment of Primary Amebic Meningoencephalitis (PAM) with Miltefosine
CNN report on Survivor of Brain Eating Amoeba
Profounda working with local Health Officials in fight to save patients life.
Profounda Licensed in Florida
IMPAVIDO NOW AVAILABLE IN THE USA
October 2018 (1)
October 2017 (1)
December 2016 (3)
September 2016 (2)
August 2016 (1)
April 2016 (2)
September 2015 (2)
July 2015 (2)
September 2014 (2)
July 2014 (1)
December 2013 (2)
November 2013 (1)
June 2013 (1)
March 2013 (1)
Nasal allergy relief